Analyst Recommendations

Citigroup analyst issues BUY recommendation for LEGN on May 31, 2024 05:30AM ET. The previous analyst recommendation was Buy.LEGN was trading at $43.33 at issue of the analyst...

May 31, 2024   LEGN 2.33%

Citigroup analyst issues NEUTRAL recommendation for CALT on May 30, 2024 07:46PM ET. CALT was trading at $38.4716 at issue of the analyst recommendation.The overall analyst consensus :...

May 30, 2024   LEGN 2.33%

BNP Paribas analyst issues NEUTRAL recommendation for NOK on May 30, 2024 08:50AM ET. The previous analyst recommendation was Neutral.NOK was trading at $3.85 at issue of the...

May 30, 2024   NOK 0.89%

Scotiabank analyst issues OUTPERFORM recommendation for KOF on May 30, 2024 09:50AM ET. The previous analyst recommendation was Outperform.KOF was trading at $94.11 at issue of the analyst...

May 30, 2024   KOF 1.82%

Jefferies analyst issues BUY recommendation for VNET on May 30, 2024 06:28AM ET. The previous analyst recommendation was Buy.VNET was trading at $1.82 at issue of the analyst...

May 30, 2024   VNET 0.21%

Scotiabank analyst issues OUTPERFORM recommendation for ADAP on May 30, 2024 06:38AM ET. ADAP was trading at $1.01 at issue of the analyst recommendation.The overall analyst consensus :...

May 30, 2024   ADAP 18.93%

RBC Capital analyst issues OUTPERFORM recommendation for AU on May 30, 2024 03:16AM ET. The previous analyst recommendation was Sector Perform.AU was trading at $24.1 at issue of...

May 30, 2024   AU 1.19%

Goldman Sachs analyst issues BUY recommendation for NVO on May 30, 2024 04:28AM ET. NVO was trading at $132.68 at issue of the analyst recommendation.The overall analyst consensus...

May 30, 2024   NVO 1.37%

Goldman Sachs analyst issues BUY recommendation for NVS on May 30, 2024 04:29AM ET. NVS was trading at $99.36 at issue of the analyst recommendation.The overall analyst consensus...

May 30, 2024   NVS -0.65%

Goldman Sachs analyst issues NEUTRAL recommendation for GSK on May 30, 2024 04:34AM ET. GSK was trading at $44.28 at issue of the analyst recommendation.The overall analyst consensus...

May 30, 2024   GSK -1.30%